Top Story

Higher BMI increased risk for 10 common cancers

August 13, 2014

Read the Perspective from Derek M. Huffman, PhD

Higher BMI increased individuals’ risks for 10 common cancers, according to results of a population-based cohort study conducted in the United Kingdom.

More than 12,000 cases of these malignancies each year in the UK can be attributed to patients being overweight or obese, and nearly 4,000 more of these cancers could occur each year if the average BMI of the country’s population continues to increase, results showed.

In the JournalsPerspective

Smoking habits persisted among cancer survivors

August 6, 2014
Nearly one-tenth of cancer survivors continued to smoke 9 years after diagnosis, according to results of a population-based study.Among that group, 83% were categorized…
figure Cover StoriesPublication Exclusive

Liquid biopsies provide extensive information, but technology carries ‘potential for overuse’

HemOnc Today, July 25, 2014
Researchers have known for decades that tumors shed cells and DNA into the bloodstream.
In the Journals

Neutrophil-to-lymphocyte ratio improved accuracy of prognostic score for castration-resistant prostate cancer

July 16, 2014
A prognostic score that included neutrophil-to-lymphocyte ratio accurately predicted OS for men with metastatic castration-resistant prostate cancer, according to study…
CME

Obesity and Comorbidities: Improving Clinical Management and Patient Outcomes in Obesity, Diabetes and Cancer

This activity is supported by an educational grant from Eisai, Inc.

11/13/2013
Obesity has increased dramatically in the past 20 years, and is considered a healthcare epidemic in the United States…
More »
CME

Molecular Testing as the Basis for Targeted Therapies in NSCLC

Supported by an independent educational grant from Boehringer Ingelheim.

3/17/2014
NSCLC comprises approximately 85% of all lung cancer cases. NSCLC histologies are primarily adenocarcinoma, squamous…
More »

Filter By:

In the Journals Perspective

Higher BMI increased risk for 10 common cancers

August 13, 2014
Higher BMI increased individuals’ risks for 10 common cancers, according to results of a population-based cohort study conducted in the United…
In the Journals Perspective

Smoking habits persisted among cancer survivors

August 6, 2014
Nearly one-tenth of cancer survivors continued to smoke 9 years after diagnosis, according to results of a population-based study.Among that group…
figure Cover Stories Publication Exclusive

Liquid biopsies provide extensive information, but technology carries ‘potential for overuse’

HemOnc Today, July 25, 2014
Researchers have known for decades that tumors shed cells and DNA into the bloodstream.
In the Journals

Neutrophil-to-lymphocyte ratio improved accuracy of prognostic score for castration-resistant prostate cancer

July 16, 2014
A prognostic score that included neutrophil-to-lymphocyte ratio accurately predicted OS for men with metastatic castration-resistant prostate cancer…
In the Journals Perspective

Testicular germ cell tumor incidence increased in Hispanic adolescents, young adults

July 14, 2014
The incidence of testicular germ cell tumors increased significantly in recent years among Hispanic adolescents and young adults, yet this trend was…
In the Journals

Sarcopenia increased risk for mortality after radical cystectomy for bladder cancer

July 2, 2014
Sarcopenia independently predicted shorter cancer-specific survival and OS among patients who underwent radical cystectomy for urothelial cancer of…
Meeting News Coverage

Hamilton to Optometry's Meeting attendees: Always get back up

June 27, 2014
PHILADELPHIA – Scott Hamilton, a retired American figure skater and Olympic gold medalist, told the story of his rollercoaster life in urging…

Top 8 lessons learned at ASCO 2014

June 25, 2014
The theme of this year’s ASCO Annual Meeting, “Science and Society,” emphasized patient-centered focus — looking at the full…
Meeting News Coverage Perspective

Novel PD-L1 antibody demonstrated activity in metastatic urothelial bladder cancer

June 18, 2014
CHICAGO — Patients with metastatic urothelial bladder cancer and PD-L1–positive disease responded to treatment with the monoclonal…
Meeting News Coverage Perspective

Addition of nivolumab to sunitinib or pazopanib induced response in mRCC

June 12, 2014
CHICAGO — The PD-1 immune checkpoint inhibitor antibody nivolumab in combination with either sunitinib or pazopanib yielded encouraging…
More Headlines »